Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Израиль, Тель-Авів
Ofer Merimsky
41 жылдар тәжірибе
аккредитациялар :
Аккредитация :
| Израиль | Түркия | Австрия | |
| Сүт безі рагында химиотерапия | бастап $22,500 | бастап $1,200 | бастап $15,000 |
| Протонды-сәулелік терапия | бастап $48,000 | бастап $70,000 | бастап $80,000 |
| Сүт безі қатерлі ісігі кезіндегі протондық терапия | - | бастап $30,000 | бастап $55,000 |
| Сүйекті резекциялау | - | бастап $8,000 | бастап $25,000 |
| Простата безінің қатерлі ісігін емдеуге арналған протондық терапия | - | бастап $30,000 | бастап $80,000 |
Клиника Ассута (Assuta) — Израильдегі ең ірі жеке медициналық орталық. Госпиталь онкология, ортопедия, нейро-, кардиохирургия және бедеулікті емдеуге маманданған. Елдегі барлық операциялардың 13% Ассутада өткізіледі, бұл оны хирургия бойынша жетекші орталық етеді.
Емдеудің сапасы мен қауіпсіздігі үшін аурухана американдық Joint Commission International аккредитациясын алды.
Әр жыл сайын Ассута желісінің дәрігерлері 92 000-нан астам операция, 685 000 диагностикалық процедура және 16 000 ЭКО циклдарын өткізеді.
Сураски медициналық орталығының жұмсақ тіндер мен сүйек онкологиясы бөлімшесін 25 жылдан астам басқарған, саркоманы емдеудегі жетекші маман.
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Сураски медициналық орталығының балалар гематоонкологиясы бөлімінің директоры — балалардағы сүйек қатерлі ісігін емдеуге маманданған.
Tel Aviv Sourasky Medical Center and Sheba Medical Center are the primary Israeli hospitals for chondrosarcoma treatment. These JCI-accredited facilities feature dedicated National Sarcoma Centers. They use multidisciplinary oncology boards to plan complex bone tumor removals. Leading specialists like Prof. Ofer Merimsky oversee treatment protocols.
Bookimed Expert Insight: Sourasky Medical Center reports a 90% success rate for oncology treatments. This performance often stems from their high patient volume. They treat over 1,800,000 people annually across 240 specialized departments. Choosing a high-volume center like this ensures access to doctors who see rare bone cancers daily.
Patient Consensus: Patients note that Israeli doctors prioritize limb-sparing surgeries whenever possible. Many find that the coordination between radiologists and surgeons helps speed up the diagnostic process.
Chondrosarcoma treatment in Israel is unique due to a 90% oncology success rate and specialized limb-sparing surgeries. Centers serve as national hubs for bone sarcomas. They integrate genomic profiling with advanced navigation-assisted resections. These methods preserve limb function and improve long-term mobility.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Hadassah show a pattern of high-volume specialization. Sourasky alone treats over 400,000 patients annually. This volume allows surgeons like Dr. Sternheim Amir to focus exclusively on rare bone tumors. Patients benefit from doctors who perform these complex resections or reconstructions much more frequently than general oncologists.
Patient Consensus: Patients note it is important to confirm a clinic has a dedicated multidisciplinary sarcoma board. They emphasize choosing surgeons experienced in wide-margin resections and advanced biological grafts for better functional results.
Israeli oncology centers primary treatment for chondrosarcoma is wide surgical resection. Since these tumors resist standard chemotherapy, surgeons prioritize limb-sparing techniques. Specialized facilities like Sourasky Medical Center use custom 3D-printed implants and endoprostheses to preserve mobility and function for patients.
Bookimed Expert Insight: Data shows Sourasky Medical Center (Ichilov) performs over 34,000 operations annually with a 90% oncology success rate. Patients seeking treatment there gain access to the National Sarcoma Center. This concentration of expertise is vital because chondrosarcoma requires precise grading by dedicated sarcoma pathologists to prevent recurrence.
Patient Consensus: Patients emphasize the importance of getting a second opinion from a sarcoma specialist. They note that precise biopsy grading is the most critical factor in choosing the right surgical approach.
Recovery after limb-sparing surgery in Israel involves a structured multidisciplinary rehabilitation process focusing on mobility and strength. Major centers like Sourasky Medical Center provide integrated oncology and rehabilitation care. Patients typically undergo phased therapy using advanced technologies like virtual reality and robotic exoskeletons to restore independent daily function.
Bookimed Expert Insight: Israeli medical centers like Sourasky and Hadassah handle massive patient volumes, often exceeding 1,000,000 people annually. This high concentration of complex cases allows surgeons like Dr. Ofer Merimsky to refine bone and soft tissue sarcoma protocols. Data shows specialized oncology institutes in Israel offer higher success rates by linking surgical teams directly with in-house high-tech rehabilitation departments.
Patient Consensus: Patients note that physical therapy is much more intense than expected. They recommend requesting a detailed protocol early. Many suggest preparing for long-term swelling by using compression garments and staying connected with peer support groups during the years-long recovery journey.
Israeli surgeons are exceptionally experienced in pelvic and spinal chondrosarcoma resections. Major centers like Sourasky Medical Center perform over 800 bone and soft tissue tumor operations annually. Specialists utilize 3D navigation and patient-specific 3D-printed implants to achieve precise en bloc resections with clean margins.
Bookimed Expert Insight: While many countries offer general orthopedic surgery, Israel’s centers focus on extreme specialization. For instance, Dr. Jakov Bikels at Sourasky specifically heads a unit for metastatic bone lesions. This narrow focus by surgeons who manage hundreds of complex cases annually often leads to better preservation of limb and spine function.
Patient Consensus: Patients emphasize the thoroughness of the pre-surgical planning. They feel reassured by how surgeons explain the 3D mapping of the spinal tumor before the procedure.
Ideal candidates for proton-beam therapy in Israel include patients with localized, non-metastatic chondrosarcoma near sensitive organs. This precision treatment is vital for tumors at the skull base or spine. Candidates typically require high functional scores and must have completed surgical tumor removal for best results.
Bookimed Expert Insight: Sourasky Medical Center serves as the National Center for bone and soft-tissue sarcomas. It maintains a 90% average success rate for oncology treatments. While Hadassah offers specific proton technology, Sourasky handles the highest volume of complex sarcoma cases. This vast experience helps doctors precisely map radiation zones to protect vital healthy tissue.
Patient Consensus: Patients highlight that coordinating care between surgeons and radiation specialists is essential. They often note that having a dedicated team helps manage the logistical complexity of high-precision treatments.
Long-term surveillance after curative chondrosarcoma surgery in Israel involves regular physical exams and advanced imaging to monitor for recurrence. Patients typically undergo local MRI and chest CT scans every 3 to 6 months during the first 3 years. This frequency decreases to annually after 5 years.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center maintain a high 90% success rate by utilizing national centers specializing specifically in bone and soft tissue sarcomas. Data shows that specialists like Dr. Ofer Merimsky coordinate multi-stage diagnostics including scintigraphy and complex sarcoma mapping. This specialized infrastructure allows for highly personalized surveillance schedules that adjust based on the tumor grade rather than following a generic cancer protocol.
Patient Consensus: Patients emphasize the need to clarify if local MRI and chest CT scans are alternated. They note that the monitoring schedule often feels intensive but provides significant peace of mind.